{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:13:15Z","timestamp":1790053995672,"version":"4.0.1"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.autrev.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,10,14]],"date-time":"2014-10-14T15:17:08Z","timestamp":1413299828000},"page":"64-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The spectrum of opportunistic diseases complicating sarcoidosis"],"prefix":"10.1016","volume":"14","author":[{"given":"Yvan","family":"Jamilloux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Valeyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lortholary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Kerever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Lelievre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Neel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Broussolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Seve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2014.10.006_bb0005","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet"},{"issue":"4\u20135","key":"10.1016\/j.autrev.2014.10.006_bb0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.autrev.2014.01.035","article-title":"Diagnostic criteria for sarcoidosis","volume":"13","author":"Heinle","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.10.006_bb0015","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/clinids\/11.6.954","article-title":"Risk of infectious complications in patients taking glucocorticosteroids","volume":"11","author":"Stuck","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0020","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/qjmed\/hci073","article-title":"Fungal infections as a complication of therapy for sarcoidosis","volume":"98","author":"Baughman","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2014.10.006_bb0025","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2014.10.006_bb0030","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/ajg.2013.138","article-title":"Opportunistic infections with anti-tumor necrosis factor-\u03b1 therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials","volume":"108","author":"Ford","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0035","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0002-9343(74)90160-0","article-title":"Course and prognosis of sarcoidosis around the world","volume":"57","author":"Siltzbach","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0040","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1001\/archinte.1976.03630120008006","article-title":"The infectious complications of sarcoidosis: a current perspective","volume":"136","author":"Winterbauer","year":"1976","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1378\/chest.86.4.585","article-title":"Aspergillomas complicating sarcoidosis. A prospective study in 100 patients","volume":"86","author":"Wollschlager","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0050","first-page":"1360","article-title":"Fungal infections complicating pulmonary sarcoidosis","volume":"152","author":"Rubinstein","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0055","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00063198-199909000-00005","article-title":"Clinical courses and prognoses of pulmonary sarcoidosis","volume":"5","author":"Nagai","year":"1999","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0060","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0065","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0761-8425(04)71582-X","article-title":"Infections opportunistes et sarco\u00efdose","volume":"21","author":"Girard","year":"2004","journal-title":"Rev Mal Respir"},{"key":"10.1016\/j.autrev.2014.10.006_bb0070","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/qjmed\/hct052","article-title":"Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases","volume":"106","author":"Bernard","year":"2013","journal-title":"QJM"},{"key":"10.1016\/j.autrev.2014.10.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000000318","article-title":"Progressive multifocal leukoencephalopathy in patients with sarcoidosis","author":"Jamilloux","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0080","series-title":"Cochrane handbook for systematic reviews of interventions. Chichester, England","author":"Cochrane Collaboration","year":"2008"},{"key":"10.1016\/j.autrev.2014.10.006_bb0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1086\/313756","article-title":"Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America","volume":"30","author":"Stevens","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0090","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0100","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0105","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0110","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1001\/jama.2011.10","article-title":"Sarcoidosis: clinical presentation, immunopathogenesis, and therapeutics","volume":"305","author":"Iannuzzi","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2014.10.006_bb0115","doi-asserted-by":"crossref","first-page":"ix","DOI":"10.1016\/j.ccm.2008.03.012","article-title":"Treatment of sarcoidosis","volume":"29","author":"Baughman","year":"2008","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0120","first-page":"60","article-title":"Methotrexate is steroid sparing in acute sarcoidosis: results of a double blind, randomized trial","volume":"17","author":"Baughman","year":"2000","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0125","first-page":"43","article-title":"Leflunomide for chronic sarcoidosis","volume":"21","author":"Baughman","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0130","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1212\/WNL.0b013e318212aafb","article-title":"Mycophenolate mofetil may be effective in CNS sarcoidosis but not in sarcoid myopathy","volume":"76","author":"Androdias","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0135","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1055\/s-0030-1262218","article-title":"Treatment of sarcoidosis","volume":"31","author":"Lazar","year":"2010","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0140","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1378\/chest.12-1728","article-title":"Methotrexate vs azathioprine in second-line therapy of sarcoidosis","volume":"144","author":"Vorselaars","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0145","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.rmed.2009.12.009","article-title":"Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study","volume":"104","author":"Schutt","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0150","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/MCP.0b013e3283642a7a","article-title":"Multinational evidence-based World Association of Sarcoidosis and Other Granulomatous Disorders recommendations for the use of methotrexate in sarcoidosis: integrating systematic literature research and expert opinion of sarcoidologists worldwide","volume":"19","author":"Cremers","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0155","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","article-title":"Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement","volume":"174","author":"Baughman","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0160","first-page":"218","article-title":"Long-term treatment with infliximab in patients with sarcoidosis","volume":"83","author":"Hostettler","year":"2012","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1183\/09031936.00051907","article-title":"Efficacy of infliximab in extrapulmonary sarcoidosis: results from a randomised trial","volume":"31","author":"Judson","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0170","first-page":"201","article-title":"A double-blinded, randomized, placebo-controlled trial of infliximab in subjects with active pulmonary sarcoidosis","volume":"23","author":"Rossman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0012-3692(15)50471-6","article-title":"Etanercept for refractory ocular sarcoidosis: results of a double-blind randomized trial","volume":"128","author":"Baughman","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0180","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1164\/ajrccm.184.10.1214","article-title":"Efficacy of adalimumab in chronically active and symptomatic patients with sarcoidosis","volume":"184","author":"Kamphuis","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0185","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1752-699X.2011.00276.x","article-title":"Effect of the TNF-\u03b1 inhibitor adalimumab in patients with recalcitrant sarcoidosis: a prospective observational study using FDG-PET","volume":"6","author":"Milman","year":"2012","journal-title":"Clin Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0190","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semarthrit.2011.12.006","article-title":"Efficacy and safety of TNF antagonists in sarcoidosis: data from the Spanish registry of biologics BIOBADASER and a systematic review","volume":"42","author":"Maneiro","year":"2012","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0195","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/rheumatology\/keq242","volume":"50","author":"Galloway","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0200","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0205","doi-asserted-by":"crossref","first-page":"21463","DOI":"10.3390\/ijms141121463","article-title":"Imbalance between Th17 and regulatory T-cells in sarcoidosis","volume":"14","author":"Huang","year":"2013","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2014.10.006_bb0210","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.10.006_bb0215","first-page":"74","article-title":"Ambivalence of CD4 lymphocytopenia in sarcoidosis","volume":"20","author":"Gentil","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0220","first-page":"129","article-title":"Does peripheral blood T-lymphocyte population distribution in sarcoidosis provide a prognostic clue?","volume":"8","author":"Desrues","year":"1991","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0225","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1136\/thx.42.4.250","article-title":"Lack of immune deficiency in sarcoidosis: compartmentalisation of the immune response","volume":"42","author":"Hudspith","year":"1987","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2014.10.006_bb0230","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.revmed.2012.02.005","article-title":"Granulomatosis and primary immunodeficiency in adulthood","volume":"34","author":"Pavic","year":"2013","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2014.10.006_bb0235","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1086\/606059","article-title":"Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect","volume":"49","author":"Malphettes","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/clim.1999.4725","article-title":"Common variable immunodeficiency: clinical and immunological features of 248 patients","volume":"92","author":"Cunningham-Rundles","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0245","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2014.10.006_bb0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000355957","article-title":"Cytomegalovirus disease in patients with common variable immunodeficiency: three case reports","volume":"163","author":"Kralickova","year":"2014","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0255","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1183\/09031936.00189011","article-title":"Granulomatosis-associated common variable immunodeficiency disorder: a case\u2013control study versus sarcoidosis","volume":"41","author":"Bouvry","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0260","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1183\/09031936.00025513","article-title":"Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID","volume":"43","author":"Kollert","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0265","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1183\/09031936.00170013","article-title":"Bronchoalveolar lavage cytology resembles sarcoidosis in a subgroup of granulomatous CVID","volume":"43","author":"Naccache","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0270","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.revmed.2007.05.030","article-title":"Systemic corticosteroid treatment and risk of infectious diseases","volume":"28","author":"Dussauze","year":"2007","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2014.10.006_bb0275","first-page":"1473","article-title":"Immune status and risk for infection in patients receiving chronic immunosuppressive therapy","volume":"32","author":"Gl\u00fcck","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0280","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0165-5728(00)00298-8","article-title":"Molecular mechanisms and Th1\/Th2 pathways in corticosteroid regulation of cytokine production","volume":"109","author":"Kovalovsky","year":"2000","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0285","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.emcpn.2005.06.002","article-title":"Sarco\u00efdose","volume":"2","author":"Valeyre","year":"2005","journal-title":"EMC Pneumol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0290","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0049-0172(95)80009-3","article-title":"Infections during low-dose methotrexate treatment in rheumatoid arthritis","volume":"24","author":"Boerbooms","year":"1995","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0295","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00290521","article-title":"Long-term tolerability of methotrexate at doses exceeding 15mg per week in rheumatoid arthritis","volume":"15","author":"Schnabel","year":"1996","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2014.10.006_bb0300","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/art.21568","article-title":"Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy","volume":"54","author":"Wolfe","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0305","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/rheumatology\/kem076","article-title":"Anti-rheumatic drug use and risk of serious infections in rheumatoid arthritis","volume":"46","author":"Bernatsky","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0310","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1164\/ajrccm.150.1.8025760","article-title":"Opportunistic infection during treatment with low dose methotrexate","volume":"150","author":"LeMense","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0315","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/0002-9343(91)80008-A","article-title":"Herpes zoster in patients with rheumatoid arthritis treated with weekly, low-dose methotrexate","volume":"90","author":"Antonelli","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S1521-6942(02)00107-9","article-title":"Infections and biological therapy in rheumatoid arthritis","volume":"17","author":"Cunnane","year":"2003","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0325","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.autrev.2008.05.001","article-title":"DMARDS and infections in rheumatoid arthritis","volume":"8","author":"Caporali","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.10.006_bb0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1399-3062.2009.00407.x","article-title":"Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity","volume":"11","author":"Ritter","year":"2009","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0335","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jneuroim.2012.04.016","article-title":"Opportunistic infections in myasthenia gravis treated with mycophenolate mofetil","volume":"249","author":"Termsarasab","year":"2012","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0340","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0889-857X(05)70327-6","article-title":"Infectious complications of immunosuppressive therapy in patients with rheumatic diseases","volume":"23","author":"Segal","year":"1997","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.autrev.2014.10.006_bb0345","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/art.21978","article-title":"Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register","volume":"54","author":"Dixon","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MD.0b013e318211106a","article-title":"TNF-\u03b1 antagonist use and risk of hospitalization for infection in a national cohort of veterans with rheumatoid arthritis","volume":"90","author":"Lane","year":"2011","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2014.10.006_bb0355","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/art.22504","article-title":"Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists","volume":"56","author":"Curtis","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0360","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2014.10.006_bb0365","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/rheumatology\/kes305","article-title":"The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment","volume":"52","author":"Listing","year":"2013","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0370","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1378\/chest.12-2820","article-title":"Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study","volume":"144","author":"Lanternier","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0375","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1001\/jama.2013.1099","article-title":"Association between the initiation of anti-tumor necrosis factor therapy and the risk of herpes zoster","volume":"309","author":"Winthrop","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.autrev.2014.10.006_bb0380","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S1473-3099(08)70227-5","article-title":"Tumour necrosis factor antagonists: structure, function, and tuberculosis risks","volume":"8","author":"Wallis","year":"2008","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0385","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1002\/art.24632","article-title":"Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: the three-year prospective French Research Axed on Tolerance of Biotherapies registry","volume":"60","author":"Tubach","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2014.10.006_bb0390","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1136\/ard.2010.137422","article-title":"Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry","volume":"70","author":"Salmon-Ceron","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0395","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/bmj.2.5213.1617","article-title":"Mycobacterium tuberculosis in the aetiology of sarcoidosis","volume":"2","author":"SCADDING","year":"1960","journal-title":"Br Med J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0400","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1378\/chest.114.2.626","article-title":"A case of concomitant tuberculosis and sarcoidosis with mycobacterial DNA present in the sarcoid lesion","volume":"114","author":"Wong","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0405","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1165\/rcmb.2010-0433TR","article-title":"Evidence for mycobacteria in sarcoidosis","volume":"45","author":"Brownell","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0410","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/jid.1953.71","article-title":"Isoniazid in the treatment of sarcoidosis; a preliminary report","volume":"21","author":"Edelson","year":"1953","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0415","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1055\/s-0032-1333469","article-title":"Tuberculosis and HIV coinfection","volume":"34","author":"Gray","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0420","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMra1200894","article-title":"Tuberculosis","volume":"368","author":"Zumla","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0425","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1086\/339548","article-title":"Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome","volume":"34","author":"Sepkowitz","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0430","first-page":"130","article-title":"Tuberculin skin test among pulmonary sarcoidosis patients with and without tuberculosis: its utility for the screening of the two conditions in tuberculosis-endemic regions","volume":"23","author":"Smith-Rohrberg","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0435","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3109\/00365548.2011.582141","article-title":"Quantiferon test for tuberculosis screening in sarcoidosis patients","volume":"43","author":"Milman","year":"2011","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0440","first-page":"95","article-title":"Interferon gamma release assay (QuantiFERON-TB Gold In Tube) in patients of sarcoidosis from a population with high prevalence of tuberculosis infection","volume":"28","author":"Gupta","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0445","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2014.10.006_bb0450","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","article-title":"Screening for tuberculosis infection prior to initiation of anti-TNF therapy","volume":"8","author":"Lalvani","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2014.10.006_bb0455","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons. Cryptococcal Active Surveillance Group","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0460","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1086\/322597","article-title":"Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy","volume":"33","author":"Pappas","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0465","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pmed.0040021","article-title":"Determinants of disease presentation and outcome during cryptococcosis: the CryptoA\/D study","volume":"4","author":"Dromer","year":"2007","journal-title":"PLoS Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0470","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/0036554021000026969","article-title":"Cryptococcal meningitis and sarcoidosis","volume":"34","author":"Ross","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0475","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1086\/314606","article-title":"Cryptococcosis: population-based multistate active surveillance and risk factors in human immunodeficiency virus-infected persons","volume":"179","author":"Hajjeh","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0480","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0732-8893(97)00190-9","article-title":"Cryptococcal osteomyelitis: case report and review","volume":"30","author":"Liu","year":"1998","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0485","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/00362177485380181","article-title":"Cryptococcus neoformans osteomyelitis: case report of two patients","volume":"12","author":"Nottebart","year":"1974","journal-title":"Sabouraudia"},{"key":"10.1016\/j.autrev.2014.10.006_bb0490","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00256-009-0691-0","article-title":"Cryptococcal pyarthrosis and sarcoidosis","volume":"38","author":"Geller","year":"2009","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0495","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1093\/clinids\/23.1.82","article-title":"Epidemiology of cryptococcosis in France: a 9-year survey (1985\u20131993). French Cryptococcosis Study Group","volume":"23","author":"Dromer","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0500","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/bmb\/ldh043","article-title":"Cryptococcal meningitis","volume":"72","author":"Bicanic","year":"2004","journal-title":"Br Med Bull"},{"key":"10.1016\/j.autrev.2014.10.006_bb0505","doi-asserted-by":"crossref","first-page":"336","DOI":"10.7326\/0003-4819-87-3-336","article-title":"Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases","volume":"87","author":"Delaney","year":"1977","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0510","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(04)00805-1","article-title":"Neurosarcoidosis: a clinical dilemma","volume":"3","author":"Hoitsma","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0515","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10072-008-0856-y","article-title":"Sarcoidosis as risk factor for cryptococcal meningitis in an apparently immunocompetent patient","volume":"29","author":"Cancelli","year":"2008","journal-title":"Neurol Sci"},{"key":"10.1016\/j.autrev.2014.10.006_bb0520","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1056\/NEJM198909213211205","article-title":"Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome","volume":"321","author":"Chuck","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0525","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/md.0b013e31803b52f5","article-title":"Cryptococcosis and idiopathic CD4 lymphocytopenia","volume":"86","author":"Zonios","year":"2007","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2014.10.006_bb0530","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1474-4422(10)70040-5","article-title":"Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis","volume":"9","author":"Tan","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0535","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.2009.187666","article-title":"Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression","volume":"81","author":"Gheuens","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2014.10.006_bb0540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1086\/595299","article-title":"Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study","volume":"199","author":"Engsig","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0545","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJMcpc030038","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 14-2004. A 66-year-old man with progressive neurologic deficits","volume":"350","author":"Koralnik","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2014.10.006_bb0550","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1212\/WNL.0b013e3181f73600","article-title":"Incidence of progressive multifocal leukoencephalopathy in patients without HIV","volume":"75","author":"Amend","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0555","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.nrl.0000250948.04681.96","article-title":"Review of progressive multifocal leukoencephalopathy and natalizumab","volume":"12","author":"Aksamit","year":"2006","journal-title":"Neurologist"},{"key":"10.1016\/j.autrev.2014.10.006_bb0560","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1378\/chest.83.3.572","article-title":"The association of progressive multifocal leukoencephalopathy and sarcoidosis","volume":"83","author":"Rosenbloom","year":"1983","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0565","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1749-6632.1974.tb14469.x","article-title":"Our evolving understanding of progressive multifocal leukoencephalopathy","volume":"230","author":"Richardson","year":"1974","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.autrev.2014.10.006_bb0570","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","article-title":"Progressive multifocal leukoencephalopathy","volume":"2","author":"Brooks","year":"1984","journal-title":"Neurol Clin"},{"key":"10.1016\/j.autrev.2014.10.006_bb0575","doi-asserted-by":"crossref","first-page":"e1950","DOI":"10.1371\/journal.pone.0001950","article-title":"Cryptococcal neuroradiological lesions correlate with severity during cryptococcal meningoencephalitis in HIV-positive patients in the HAART era","volume":"3","author":"Charlier","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2014.10.006_bb0580","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.clineuro.2012.06.018","article-title":"Common and uncommon imaging findings in progressive multifocal leukoencephalopathy (PML) with differential diagnostic considerations","volume":"114","author":"Horger","year":"2012","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.autrev.2014.10.006_bb0585","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1212\/WNL.0b013e31828c2fa1","article-title":"PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section","volume":"80","author":"Berger","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-199701000-00003","article-title":"Diagnosis of central nervous system complications in HIV-infected patients: cerebrospinal fluid analysis by the polymerase chain reaction","volume":"11","author":"Cinque","year":"1997","journal-title":"AIDS"},{"key":"10.1016\/j.autrev.2014.10.006_bb0595","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","article-title":"Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis","volume":"77","author":"Vulliemoz","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.autrev.2014.10.006_bb0600","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/13550280152537292","article-title":"Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside","volume":"7","author":"Aksamit","year":"2001","journal-title":"J Neurovirol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0605","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","article-title":"Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis","volume":"22","author":"De Luca","year":"2008","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.autrev.2014.10.006_bb0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","article-title":"A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes","volume":"19","author":"Clifford","year":"2013","journal-title":"J Neurovirol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0615","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","article-title":"The human polyomavirus, JCV, uses serotonin receptors to infect cells","volume":"306","author":"Elphick","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.autrev.2014.10.006_bb0620","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","article-title":"Progressive multifocal leucoencephalopathy in a patient with sarcoidosis\u2014successful treatment with cidofovir and mirtazapine","volume":"46","author":"Owczarczyk","year":"2007","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2014.10.006_bb0625","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2007.11.013","article-title":"The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases","volume":"30","author":"Boren","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2014.10.006_bb0630","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","article-title":"Progressive multifocal leukoencephalopathy in patients with HIV infection","volume":"4","author":"Berger","year":"1998","journal-title":"J Neurovirol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0635","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1183\/09031936.00226911","article-title":"Global burden of chronic pulmonary aspergillosis complicating sarcoidosis","volume":"41","author":"Denning","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0640","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1183\/09031936.00054810","article-title":"Underlying conditions in chronic pulmonary aspergillosis including simple aspergilloma","volume":"37","author":"Smith","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.autrev.2014.10.006_bb0645","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00408-011-9280-9","article-title":"Aspergillus lung disease in patients with sarcoidosis: a case series and review of the literature","volume":"189","author":"Pena","year":"2011","journal-title":"Lung"},{"key":"10.1016\/j.autrev.2014.10.006_bb0650","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1378\/chest.06-2441","article-title":"Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients","volume":"131","author":"Camuset","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0655","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1378\/chest.111.3.612","article-title":"Pulmonary aspergilloma and AIDS. A comparison of HIV-infected and HIV-negative individuals","volume":"111","author":"Addrizzo-Harris","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0660","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/thx.38.8.572","article-title":"Pulmonary aspergilloma: analysis of prognosis in relation to haemoptysis and survey of treatment","volume":"38","author":"Jewkes","year":"1983","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2014.10.006_bb0665","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.revmed.2006.07.007","article-title":"Aspergillosis in systemic diseases treated with steroids and\/or immunosuppressive drugs: report of 9 cases and review of the literature","volume":"27","author":"Stankovic","year":"2006","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.autrev.2014.10.006_bb0670","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/MD.0b013e3181775a73","article-title":"Pulmonary cavitary sarcoidosis: clinico-radiologic characteristics and natural history of a rare form of sarcoidosis","volume":"87","author":"Hours","year":"2008","journal-title":"Medicine"},{"key":"10.1016\/j.autrev.2014.10.006_bb0675","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.athoracsur.2013.10.050","article-title":"Surgical therapy of pulmonary aspergillomas: a 30-year North American experience","volume":"97","author":"Muniappan","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.autrev.2014.10.006_bb0680","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.athoracsur.2013.03.097","article-title":"Prevalence and outcomes of anatomic lung resection for hemoptysis: an analysis of the nationwide inpatient sample database","volume":"96","author":"Paul","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.autrev.2014.10.006_bb0685","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.12-1784","article-title":"A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma","volume":"143","author":"Kravitz","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0690","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1099\/jmm.0.46639-0","article-title":"Use of voriconazole in a patient with aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus","volume":"55","author":"Dannaoui","year":"2006","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0695","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/jac\/dkh507","article-title":"Mutations in the cyp51A gene and susceptibility to itraconazole in Aspergillus fumigatus serially isolated from a patient with lung aspergilloma","volume":"55","author":"Chen","year":"2005","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.autrev.2014.10.006_bb0700","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1128\/AAC.46.2.556-557.2002","article-title":"Azole cross-resistance in Aspergillus fumigatus","volume":"46","author":"Mosquera","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.autrev.2014.10.006_bb0705","doi-asserted-by":"crossref","first-page":"e182","DOI":"10.1093\/cid\/cit600","article-title":"A multistep voriconazole-related phototoxic pathway may lead to skin carcinoma: results from a French nationwide study","volume":"57","author":"Epaulard","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0710","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/thoraxjnl-2013-203988","article-title":"Cyclical caspofungin for chronic pulmonary aspergillosis in sarcoidosis","volume":"69","author":"Keir","year":"2014","journal-title":"Thorax"},{"key":"10.1016\/j.autrev.2014.10.006_bb0715","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1378\/chest.92.3.505","article-title":"Aspergilloma in sarcoid and tuberculosis","volume":"92","author":"Tomlinson","year":"1987","journal-title":"Chest"},{"key":"10.1016\/j.autrev.2014.10.006_bb0720","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.pneumo.2012.12.001","article-title":"Pulmonary nocardiosis and sarcoidosis","volume":"69","author":"Rkiouak","year":"2013","journal-title":"Rev Pneumol Clin"},{"key":"10.1016\/j.autrev.2014.10.006_bb0725","first-page":"65","article-title":"Disseminated nocardiosis mimicking exacerbation of pulmonary sarcoidosis","volume":"30","author":"Zuk","year":"2013","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0730","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurol.2008.06.012","article-title":"Nocardia brain abscess: features, therapeutic strategies and outcome","volume":"165","author":"Marnet","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.autrev.2014.10.006_bb0735","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0399-077X(87)80051-3","article-title":"Une Observation de leishmaniose chez un malade traite par corticoides pour sarcoidose","volume":"17","author":"Mulliez","year":"1987","journal-title":"Med Mal Infect"},{"key":"10.1016\/j.autrev.2014.10.006_bb0740","first-page":"94","article-title":"Herpes zoster in patients with sarcoidosis","volume":"59","author":"Miyagawa","year":"1992","journal-title":"Respir Int Rev Thorac Dis"},{"key":"10.1016\/j.autrev.2014.10.006_bb0745","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s12348-011-0041-y","article-title":"Extensive herpes zoster involvement following mycophenolate mofetil therapy for sarcoidosis","volume":"2","author":"Hegde","year":"2012","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.autrev.2014.10.006_bb0750","first-page":"797","article-title":"A case of sarcoidosis accompanied by herpes zoster encephalitis","volume":"26","author":"Kobayashi","year":"1986","journal-title":"Clin Neurol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997214002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T01:38:25Z","timestamp":1565919505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997214002183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1568997214002183"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.006","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spectrum of opportunistic diseases complicating sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}